Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Our GLP-3 RETA is produced using advanced peptide synthesis technology and undergoes strict quality control to ensure consistency and purity for laboratory investigations
its use is not approved by the FDA) insurance is far less likely to cover it
Consistent dosing is one of the simplest ways to support reliable results
These expanded clinical uses drastically widen the addressable patient population
There is also a trial specifically testing whether retatrutide prevents heart attacks and strokes (TRIUMPH-3, 1,800 people), and a head-to-head trial comparing retatrutide directly against tirzepatide (the active ingredient in Zepbound) under identical conditions (NCT06662383, 800 patients)
Women made up 56% of the Phase 2 trial cohort (89 out of 157 participants at the 12mg dose)
US$ 20.16
US$ 29.24
US$ 24.84
US$ 27.94
US$ 21.67
US$ 20.65
US$ 20.91
US$ 25.53
US$ 26.92
